Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the efficacy and safety of 360 µg induction dosing of Pegasys for 12 weeks followed by a 180 µg maintenance dose of Pegasys for 36 weeks in combination with Copegus for 48 weeks with the efficacy and safety of 180 µg fixed dosing of Pegasys in combination with Copegus for 48 weeks in patients with genotype 1 chronic hepatitis C infection of high viral titer and baseline body weight equal to or greater than 85 kg
Critère d'inclusion
- genotype 1 chronic hepatitis C infection of high viral titer and baseline body weight greater than or equal to 85 kg